The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's ...
Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday ...
FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a planned Q2 launch. Read more ...
Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...
Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...
Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...
We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...
Opinion
MPs in move to allow assisted dying for those with neurodegenerative illnesses at 12 months leftMPs from the Labour Party, Conservatives, Liberal Democrats, and Green Party have come together to back a new amendment to the Terminally Ill Adults (End of Life) Bill to allow those with ...
People with neurodegenerative illnesses such as motor neurone disease (MND) should be able to request assisted dying with 12 ...
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback